Levalbuterol hydrochloride
Class
Bronchodilators
Subclass
Short-acting beta-agonists
Substance name
Levalbuterol hydrochloride, levosalbutamol
Brand names
Xopenex®
Dosage and administration
Adults patients
Prevention and treatment of bronchospasm in patients with reversible obstructive airway disease
Indications for use
Labeled indications
Adults
Safety risks
Contraindications
Hypersensitivity to levalbuterol or its components, or racemic albuterol
Warnings and precautions
Asthma exacerbation
Cardiac arrest
Cardiovascular adverse events
Decreased drug efficacy
Decreased serum potassium
Drug hypersensitivity reaction
Paradoxical bronchospasm
Sympathomimetic adverse effects
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Any modality
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters
Breastfeeding
Use only if benefits outweigh potential risks.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource